Suppr超能文献

[精神分裂症患者戒烟与减少吸烟量]

[Stopping and reducing smoking in patients with schizophrenia].

作者信息

Underner M, Perriot J, Brousse G, de Chazeron I, Schmitt A, Peiffer G, Harika-Germaneau G, Jaafari N

机构信息

Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS 10587, 86021 Poitiers cedex, France.

Centre de tabacologie, dispensaire Emile-Roux, 63100 Clermont-Ferrand, France; Service de psychiatrie-addictologie, CMP-B, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France.

出版信息

Encephale. 2019 Sep;45(4):345-356. doi: 10.1016/j.encep.2019.04.067. Epub 2019 May 29.

Abstract

OBJECTIVES

This systematic review of the literature looked at data on pharmacological and non-pharmacological strategies of smoking cessation and reduction of consumption in patients with schizophrenia.

METHOD

The research was conducted on Medline for the period 1980-2018. We included randomized controlled trials, including preliminary studies of stable schizophrenic patients with no other severe psychiatric disorder and no other substance use than tobacco, treated with antipsychotic medications. Individual or group smoking cessation programs with or without pharmacological treatment, including a validation of abstinence, were included.

RESULTS

Pharmacotherapies for nicotine dependence-nicotine replacement therapy (n=3), bupropion (n=6), varenicline (n=8), association of medications (n=4)-were used in 23 studies combined with behavioral support. Compared to the placebo, bupropion and varenicline at the end of treatment were found to be the most effective pharmacotherapies to stop or reduce smoking and control craving. All the medications were well tolerated and did not lead to aggravation of psychosis or changes in symptoms. Non-pharmacological interventions: behavioral and cognitive therapies (n=5) combined with pharmacological treatment facilitated the management of smoking risk situations and improved adherence to antipsychotics; other psychosocial interventions (n=7) allowed the development of social skills; contigency management strategies with financial reinforcement can be used (n=4); the practice of physical activity and the use of an electronic cigarette allowed reduction of tobacco consumption. The results of transcranial electromagnetic stimulation studies (n=6) were discordant. Atypical antipsychotics appear to be associated with a better success of attempts to stop smoking.

CONCLUSION

Smoking cessation strategies for patients with schizophrenia appear to be effective and should combine (1) smoking cessation medications with sufficient duration, (2) diversified psychosocial approaches and (3) physical activity practice.

摘要

目的

本系统文献综述研究了精神分裂症患者戒烟及减少吸烟量的药物和非药物策略的数据。

方法

研究在1980年至2018年期间的Medline数据库上进行。我们纳入了随机对照试验,包括对无其他严重精神疾病且除烟草外无其他物质使用的稳定精神分裂症患者进行的初步研究,这些患者接受抗精神病药物治疗。纳入了有或没有药物治疗的个体或团体戒烟计划,包括戒烟验证。

结果

23项研究使用了用于尼古丁依赖的药物治疗——尼古丁替代疗法(n = 3)、安非他酮(n = 6)、伐尼克兰(n = 8)、联合用药(n = 4)——并结合行为支持。与安慰剂相比,治疗结束时发现安非他酮和伐尼克兰是最有效的戒烟或减少吸烟及控制烟瘾的药物治疗方法。所有药物耐受性良好,未导致精神病加重或症状改变。非药物干预:行为和认知疗法(n = 5)与药物治疗相结合有助于管理吸烟风险情况并提高对抗精神病药物的依从性;其他心理社会干预(n = 7)有助于发展社交技能;可采用有经济强化的应急管理策略(n = 4);体育活动和使用电子烟可减少烟草消费。经颅电磁刺激研究(n = 6)的结果不一致。非典型抗精神病药物似乎与戒烟尝试的更好成功率相关。

结论

精神分裂症患者的戒烟策略似乎有效,应结合(1)足够疗程的戒烟药物,(2)多样化的心理社会方法,以及(3)体育活动。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验